The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
863
February 7, 1992
View Complete Issue         Table of Contents 2019 
Safety of Terfenadine and Astemizole
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Safety of Terfenadine and Astemizole
February 7, 1992 (Issue: 863)
Terfenadine (Seldane - Marion Merrell Dow) and astemizole (Hismanal - Janssen) are nonsedating antihistamines widely used to treat symptoms of allergic rhinitis (Medical Letter, 27:65, 1985; 31:43, 1989). Both are available without a prescription...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Safety of Terfenadine and Astemizole
Article code: 863a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.